3 results
Approved WMOCompleted
The purpose of the study is to investigate to what extent WCK 4282 is safe and tolerated. It will also be investigated how quickly and to what extent WCK 4282 is absorbed and eliminated from the body (this is called pharmacokinetics).
Approved WMOCompleted
To determine the activity (as measured by objective response rate by RECIST1.1) of monalizumab and trastuzumab in patients with metastatic HER2-positive breast cancer.
Approved WMOWill not start
The primary objectives are to evaluate preliminary data on the safety and performance of theEmboliner embolic protection catheter.Safety:Assess procedural safety risksPerformance:Assess the technical performance in conjunction with a TAVR procedure.